Purpose: Treatment results for locally recurrent rectal cancers are poor. T
his is a result of the fact that surgery is hampered due to the severance o
f the anatomical planes during the primary procedure and that radiotherapy
is limited by normal tissue tolerance, especially after previous irradiatio
n. This paper describes the results of a combined treatment modality in thi
s patient group.
Methods and Materials: From 1994 to 1998, 37 patients with locally recurren
t rectal cancer, but without distant metastatic disease, received a combine
d treatment consisting of 50.4 Gy preoperative irradiation or, in case of p
revious radiotherapy, 30 Gy reirradiation or no irradiation, followed by ra
dical surgery and intraoperative electron beam radiotherapy boost.
Results: Fifteen patients received a radical resection (RO), eight a micros
copic irradical resection (R1), and 14 a macroscopic irradical resection (R
2). The overall 3-year local control (LC), disease-free survival (DFS), and
overall survival rates were 60%, 32%, and 58% respectively. Radicality of
resection (R0/R1 vs. R2) turned out to be the significant factor for improv
ed survival (p < 0.05), DFS (p = 0.0008), and LC (p = 0.01). Preoperative (
re-)irradiation is the other significant factor in survival (p = 0.005) and
DFS (p = 0.001) and was almost significant for LC (p = 0.08). After extern
al beam radiation therapy (EBRT) a significantly higher resection rate was
obtained (R0/R1 vs. R2 p = 0.001). Symptomatic peripheral local recurrences
have a significantly worse prognosis and higher rate of R2-resection (p =
0.0005).
Conclusion: Centralization of locally recurrent rectal cancer patients enab
led the development of an aggressive multimodality treatment, which in turn
led to promising results, Distant failure is still a drawback. (C) 1999 El
sevier Science Inc.